Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Eisai Pharmaceuticals India Pvt. Ltd

Clinical trials sponsored by Eisai Pharmaceuticals India Pvt. Ltd, explained in plain language.

Now part of Eisai Co., Ltd. ESAIY OTC

Indian subsidiary of Eisai, a Japanese pharmaceutical company focused on neurology and oncology.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Lenvatinib under the microscope: safety check for tough thyroid cancers

Disease control Completed

This study looked at the safety of the drug lenvatinib in 50 people with advanced thyroid cancer that had stopped responding to radioactive iodine treatment. Researchers tracked side effects and how often patients needed to lower their dose. They also checked whether tumors shran…

Phase: PHASE4 • Sponsor: Eisai Pharmaceuticals India Pvt. Ltd • Aim: Disease control

Last updated Jun 27, 2026 09:11 UTC